Drug Delivery Systems

"Drug Delivery Systems" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.

Descriptor ID	D016503
MeSH Number(s)	E02.319.300
Concept/Terms	Drug Delivery Systems Drug Delivery Systems Delivery System, Drug Delivery Systems, Drug Drug Delivery System System, Drug Delivery Systems, Drug Delivery Drug Targeting Drug Targetings Targeting, Drug Targetings, Drug

Below are MeSH descriptors whose meaning is more general than "Drug Delivery Systems".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Delivery Systems [E02.319.300]

Below are MeSH descriptors whose meaning is more specific than "Drug Delivery Systems".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Delivery Systems" by people in this website by year, and whether "Drug Delivery Systems" was a major or minor topic of these publications.

Bar chart showing 60 publications over 16 distinct years, with a maximum of 10 publications in 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2001	1	0	1
2003	3	2	5
2004	3	1	4
2005	1	2	3
2006	5	2	7
2007	5	4	9
2008	2	3	5
2009	5	5	10
2010	2	2	4
2011	2	3	5
2012	1	0	1
2015	1	0	1
2016	1	0	1
2017	0	2	2
2018	0	1	1
2019	1	0	1

Below are the most recent publications written about "Drug Delivery Systems" by people in Profiles.

Rajapreyar I, Samson R, Ennezat PV, Jemtel THL. Targeted Mono-Therapy for Newly Diagnosed Dilated Cardiomyopathy. J Card Fail. 2019 Aug; 25(8):686-689.

View in: PubMed
Tepper SJ. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment. Headache. 2018 11; 58 Suppl 3:238-275.

View in: PubMed
Silberstein SD. A review of clinical safety data for sumatriptan nasal powder administered by a breath powered exhalation delivery system in the acute treatment of migraine. Expert Opin Drug Saf. 2018 Jan; 17(1):89-97.

View in: PubMed
Pillai A, Schooler NR, Peter D, Looney SW, Goff DC, Kopelowicz A, Lauriello J, Manschreck T, Mendelowitz A, Miller DD, Severe JB, Wilson DR, Ames D, Bustillo J, Kane JM, Buckley PF. Predicting relapse in schizophrenia: Is BDNF a plausible biological marker? Schizophr Res. 2018 03; 193:263-268.

View in: PubMed
Azzi J, Yin Q, Uehara M, Ohori S, Tang L, Cai K, Ichimura T, McGrath M, Maarouf O, Kefaloyianni E, Loughhead S, Petr J, Sun Q, Kwon M, Tullius S, von Andrian UH, Cheng J, Abdi R. Targeted Delivery of Immunomodulators to Lymph Nodes. Cell Rep. 2016 05 10; 15(6):1202-13.

View in: PubMed
Estella-Hermoso de Mendoza A, Castello-Cros R, Imbuluzqueta E, Cirauqui C, Pippa R, Odero MD, Blanco-Prieto MJ. Lipid Nanosystems Enhance the Bioavailability and the Therapeutic Efficacy of FTY720 in Acute Myeloid Leukemia. J Biomed Nanotechnol. 2015 Apr; 11(4):691-701.

View in: PubMed
Dasgupta I, Tanifum EA, Srivastava M, Phatak SS, Cavasotto CN, Analoui M, Annapragada A. Non inflammatory boronate based glucose-responsive insulin delivery systems. PLoS One. 2012; 7(1):e29585.

View in: PubMed
Altunbas A, Lee SJ, Rajasekaran SA, Schneider JP, Pochan DJ. Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles. Biomaterials. 2011 Sep; 32(25):5906-14.

View in: PubMed
Sacco E, Metalli D, Spinelli M, Manzoni R, Samalikova M, Grandori R, Morrione A, Traversa S, Alberghina L, Vanoni M. Novel RasGRF1-derived Tat-fused peptides inhibiting Ras-dependent proliferation and migration in mouse and human cancer cells. Biotechnol Adv. 2012 Jan-Feb; 30(1):233-43.

View in: PubMed
Ramgolam VS, Sha Y, Marcus KL, Choudhary N, Troiani L, Chopra M, Markovic-Plese S. B cells as a therapeutic target for IFN-ß in relapsing-remitting multiple sclerosis. J Immunol. 2011 Apr 01; 186(7):4518-26.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement